Is Europe sleepwalking into tech irrelevance? https://www.euractiv.com/section/digital/opinion/is-europe-sleepwalking-into-tech-irrelevance/?utm_source=dlvr.it&utm_medium=mastodon #AI #artificialintelligence #geopolitics #researchanddevelopment
#AI #ArtificialIntelligence #geopolitics #researchanddevelopment
Believe it or not but decades later the EU unitary patent system is finally becoming a reality. The entry into force is set for 1 June, after Germany finally submitted its ratification
#UnitaryPatent #EU #Innovation #R&D #ResearchAndDevelopment
https://data.consilium.europa.eu/doc/document/ST-6070-2023-INIT/en/pdf
#unitarypatent #eu #innovation #r #researchanddevelopment
Revenues down for Moderna, up for Regeneron in Q1 —Roche opens new institute to advance research in human model systems — ImmunoGen reports positive top-line data from ovarian cancer therapy trial -- See more on our front page news http://bit.ly/w28kSd #earnings #moderna #regeneron #roche #researchanddevelopment #clinicaltrials #ovariancancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#earnings #moderna #regeneron #roche #researchanddevelopment #clinicaltrials #ovariancancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Our (MFF Charles University, HiLASE Centre, Czech Technical University) publication on fully dry #glass metallisation is out. Glass is ideal for multilayer, high-power, low-loss #microwave circuits. Easily integrated with photonics. Ideal for Paul traps. https://authors.elsevier.com/a/1g%7E9WcXa-4XKA #researchanddevelopment
#glass #microwave #researchanddevelopment
Big Pharma’s R&D spending flatlined in 2022: What it means for the industry —Bluebird Bio submits BLA for sickle cell disease gene therapy—Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy-- See more on our front page news http://bit.ly/w28kSd #bigpharma #researchanddevelopment #bluebirdbio #sicklecelldisease #genetherapy #obesity #elililly #novonordisk #wegovy #mounjaro #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#bigpharma #researchanddevelopment #bluebirdbio #Sicklecelldisease #genetherapy #obesity #elililly #novonordisk #wegovy #mounjaro #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Lilly expects US Medicare to reverse course, fully cover Alzheimer's drugs —Boehringer taps RetinAI for AI boost to eye disease R&D—Big pharma holds steady on research spending-- See more on our front page news http://bit.ly/w28kSd #researchanddevelopment #artificialintelligence #ai #bigpharma #boehringeringelheim #elililly #medicare #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#researchanddevelopment #artificialintelligence #ai #bigpharma #boehringeringelheim #elililly #medicare #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Q1 claimed the highest number of trial starts in 2022 — AbbVie knocks down earnings forecast due to IPR&D charge — FDA forces unproven premature birth drug Makena off market -- See more on our front page news http://bit.ly/w28kSd #abbvie #researchanddevelopment #fda #makena #pretermbirth #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#abbvie #researchanddevelopment #FdA #makena #PretermBirth #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Lilly’s Alzheimer’s struggles continue as preclinical asset fails phase III— AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial — Bayer plans to double down on US pharma R&D in 2023-- See more on our front page news http://bit.ly/w28kSd #elililly #astrazeneca #alzheimers #clinicaltrials #researchanddevelopment #bayer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#elililly #astrazeneca #alzheimers #clinicaltrials #researchanddevelopment #Bayer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Novo Nordisk recruits new staff, lays off others as US R&D consolidated in Boston— Is pharma patient centric? Not according to most doctors—Eli Lilly licenses non opioid pain med for $40M upfront-- See more on our front page news http://bit.ly/w28kSd #novonordisk #researchanddevelopment #layoffs #hirings #boston #pain #elililly #patients #physicians #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#novonordisk #researchanddevelopment #layoffs #hirings #boston #pain #elililly #patients #physicians #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
US Treasury and White House to Hold Regular Meetings on CBDCs and Payment Innovations - On March 1, 2023, Nellie Liang, undersecretary for domestic finance at the U.S. Tr... - https://news.bitcoin.com/us-treasury-and-white-house-to-hold-regular-meetings-on-cbdcs-and-payment-innovations/ #centralbankdigitalcurrencies #councilofeconomicadvisors #globalfinancialleadership #nationaleconomiccouncil #nationalsecuritycouncil #researchanddevelopment #financialregulation #paymentsinnovations #news
#news #paymentsinnovations #financialregulation #researchanddevelopment #nationalsecuritycouncil #nationaleconomiccouncil #globalfinancialleadership #councilofeconomicadvisors #centralbankdigitalcurrencies
Upcoming FDA decisions: vaccines, neurology, and more— Should Abbott and DexCom be worried about Apple's latest CGM news?—AstraZeneca expands Canada R&D work, to add 500 jobs-- See more on our front page news http://bit.ly/w28kSd #fda #neurology #vaccines #covid #covid19 #apple #diabetes #medtech #abbottlabs #dexcom #canada #jobs #researchanddevelopment #hirings #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#FdA #neurology #vaccines #covid #covid19 #apple #diabetes #medtech #abbottlabs #dexcom #canada #jobs #researchanddevelopment #hirings #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Amid bankruptcy, Clovis reveals more regulatory troubles for Rubraca — Reed relinquishes R&D reins at Sanofi to pursue new opportunity —5 Ways ChatGPT will change healthcare forever-- See more on our front page news http://bit.ly/w28kSd #clovisoncology #bankruptcy #sanofi #researchanddevelopment #healthcare #chatgpt #ai #artificialintelligence #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#clovisoncology #bankruptcy #Sanofi #researchanddevelopment #healthcare #chatgpt #ai #artificialintelligence #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
“Nothing is more dangerous than a man who knows the past.” ~Gleeman, The Wheel of Time
Past events aren’t a perfect predictor of future trends, but they’re certainly not irrelevant occurrences either. We tallied publicly known cyber loss events each month over the last decade, and tell the story of that data in the Information Risk Insights Study 2022, answering questions like: "Are incidents occurring more often of late?” Download the Report to find out: https://www.cyentia.com/iris-2022/
#infosec #cybersecurity #risk #riskmanagement #cyberriskquantification #research #published #data #analytics #stats #researchanddevelopment #CISO #industrystats #industrynews #cyberloss
#infosec #cybersecurity #risk #riskmanagement #cyberriskquantification #research #published #data #analytics #stats #researchanddevelopment #ciso #industrystats #industrynews #cyberloss
I currently have part-time availability from March 1st onwards - Xarma Ltd would be pleased to help you meet your #technical needs, including - but not limited to! - the following:
* #Observability - #DataDog and #Logging
* #Web app / #SaaS development
* Data engineering and #architecture
* #Agile coaching
* #Interim #leadership positions
* #ResearchAndDevelopment
* #Performance improvement
* #Process improvement
* #Event processing
and more!
Interested? Drop us a line - enquiries@xarma.co
#event #process #performance #researchanddevelopment #leadership #interim #agile #architecture #saas #web #logging #datadog #observability #technical
I read and write a LOT of technical papers. I always have. One of the things I have found through my experience reading and writing - is that authors, in their passion about a topic, often forget to bring the reader along. They don't meet their audience where they are at - and THEN whisk them off to the research destination they are so excited to explore. They jump into a story midway - challenging the reader to struggle through acronyms, intuit what problem they are solving, or guess at how they plan to measure success.
A set of questions I used to evaluate research proposals 20 years ago is still one of my most often referenced "cheat sheets" I share with technical authors.
"The Heilmeier Catechism" - A few questions that, when answered, make for excellent proposals or presentations.
* What are you trying to do? Articulate your objectives using absolutely no jargon.
* How is it done today, and what are the limits of current practice?
* What is new in your approach and why do you think it will be successful?
* Who cares? If you are successful, what difference will it make?
* What are the risks?
* How much will it cost?
* How long will it take?
* What are the mid-term and final “exams” to check for success?
Source:
https://www.darpa.mil/work-with-us/heilmeier-catechism
#writing #proposals #presentations #technicalwriting #darpa #research #researchanddevelopment #leadership #goals
#writing #proposals #presentations #technicalwriting #darpa #research #researchanddevelopment #leadership #goals
Whether you've read all of IRIS Tsunami, skimmed it, or bookmarked it for later, be sure to check out our blog post written by John Sturgis: https://www.cyentia.com/iris-tsunami-lessons/
#infosec #cybersecurity #risk #riskmanagement #cyberriskquantification #research #published #data #analytics #stats #researchanddevelopment #CISO #industrystats #industrynews #cyberloss #supplychain
#infosec #cybersecurity #risk #riskmanagement #cyberriskquantification #research #published #data #analytics #stats #researchanddevelopment #ciso #industrystats #industrynews #cyberloss #supplychain
In our new Information Risk Insights study we found that the majority of loss events involving midsize and large firms fall below 1% of their income, while the higher ratios on the other side of the spectrum are almost entirely populated by small businesses. Download the report: https://www.cyentia.com/iris/
#infosec #cybersecurity #risk #riskmanagement #cyberriskquantification #research #published #data #analytics #stats #researchanddevelopment #CISO #industrystats #industrynews #cyberloss #supplychain
#infosec #cybersecurity #risk #riskmanagement #cyberriskquantification #research #published #data #analytics #stats #researchanddevelopment #ciso #industrystats #industrynews #cyberloss #supplychain
Our team's deep understanding of research methodology, strong data analysis, communication skills, and rich cybersecurity domain expertise are just some of what makes the original research that we do at the Cyentia Institute exceptional; learn more about the work that Wade does here every day: https://www.cyentia.com/team
#team #happymonday #employee #employer #talent #infosec #cybersecurity #riskmanagement #cyberriskquantification #publication #data #researchanddevelopment
#team #happymonday #employee #employer #talent #infosec #cybersecurity #riskmanagement #cyberriskquantification #publication #data #researchanddevelopment
FDA considers major shift in COVID vaccine strategy — Biogen/ Ionis ALS therapy set for March FDA AdCom meeting — Merck KGaA shrinks U.S. research team as layoffs continue to batter industry -- See more on our front page news http://bit.ly/w28kSd #fda #covid #covid19 #vaccines #biogen #als #fda #merckkgaa #layoffs #researchanddevelopment #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#FdA #covid #covid19 #vaccines #biogen #ALS #merckkgaa #layoffs #researchanddevelopment #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
One of my favorite things about being an early member of a team/organization is writing clear documentation so other people can repeat the processes.
📦 Another great part of the early stages is unpacking lots of boxes!
And seeing offices or labs all they way back when they looked like this.
And all the progress thereafter 😆
#firsthire #research #sciencewriting #researchanddevelopment #foundingteam #startups #startuplife
#firsthire #research #sciencewriting #researchanddevelopment #foundingteam #startups #startuplife